Woodcock cites 'vigorous interest' in biosimilar development
Regulatory NewsJoanne S. Eglovitch.jpg.aspx?lang=en-us&width=480&height=640&ext=.jpg)
Biologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory Intelligence/Policy